Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Graft-versus-host Disease (GvHD)
100%
Treg
100%
NKT Cells
100%
Regulatory T Cell Therapy
100%
Invariant Natural Killer T Cells
83%
C57BL
33%
Cell number
33%
Adoptive Transfer
33%
Treg Therapy
33%
GalCer
33%
Transplantation
16%
T Cell Activation
16%
Liposomes
16%
Regulatory T Cells
16%
Cell Therapy
16%
Survival Benefit
16%
Clinical Application
16%
Paucity
16%
Balb C Mice
16%
Disease Model
16%
Peripheral Blood
16%
After Injection
16%
Therapeutic Efficacy
16%
α-galactosylceramide (α-GalCer)
16%
Disease Suppression
16%
Regulatory Cells
16%
Single Administration
16%
LiPo
16%
Tumor Effect
16%
Phase 1/2 Clinical Trial
16%
Adoptive Therapy
16%
Medicine and Dentistry
Graft Versus Host Reaction
100%
Natural Killer T Cell
100%
Cell Therapy
100%
Regulatory T Cell
100%
C57BL/6
33%
Adoptive Transfer
33%
T Cell Activation
16%
Clinical Trial
16%
Liposome
16%
Combination Therapy
16%
Disease Model
16%
Single Drug Dose
16%
Regulatory Cell
16%
Graft Versus Tumor Effect
16%
Galactosylceramide
16%
Immunology and Microbiology
Graft-Versus-Host Disease
100%
Regulatory T Cell
100%
Natural Killer T Cell
100%
Wild Type
20%
Cell Count
10%
T Cell Activation
10%
C57BL 6 Mouse
10%
Bagg Albino Mouse
10%
Graft Versus Tumor Effect
10%
Regulatory Cell
10%
Biochemistry, Genetics and Molecular Biology
Regulatory T Cell
100%
Natural Killer T Cell
100%
Wild Type
20%
Clinical Trial
10%
C57BL 6 Mouse
10%
Animal Model
10%
Cell Activation
10%
Single Drug Dose
10%
Cell Count
10%
Bagg Albino Mouse
10%
Pharmacology, Toxicology and Pharmaceutical Science
Graft Versus Host Reaction
100%
Neoplasm
20%
Combination Therapy
20%
Clinical Trial
20%
C57BL 6 Mouse
20%
Liposome
20%
Disease Model
20%
Bagg Albino Mouse
20%
Galactosylceramide
20%